Volume 4, Issue 2 pp. 107-112

Screening Guidelines for Coronary Heart Disease in Diabetes: Current Recommendations

Sarabjeet Singh MD,

Sarabjeet Singh MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

Jasleen Duggal MD,

Jasleen Duggal MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

Natalia Khosla MD,

Natalia Khosla MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

Rohit Arora MD,

Rohit Arora MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

Sarabjeet Singh MD,

Sarabjeet Singh MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

Jasleen Duggal MD,

Jasleen Duggal MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

Natalia Khosla MD,

Natalia Khosla MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

Rohit Arora MD,

Rohit Arora MD

From the Division of Cardiology, Department of Medicine, Chicago Medical School, Chicago, IL

Search for more papers by this author

First published: 13 April 2009

https://doi.org/10.1111/j.1559-4572.2008.00040.x

Citations: 1

Sarabjeet Singh, MD, Division of Cardiology, Department of Medicine, Chicago Medical School, 3001 Green Bay Road, North Chicago, IL 60064
E-mail: [email protected]

Share a link

Email
Wechat
Bluesky

Abstract

Diabetes and cardiovascular disease are so intertwined with one another that the presence of one prompts a search for the other. Diabetes has been considered to be equivalent to coronary heart disease (CHD), and conversely many patients with known CHD have concomitant diabetes or its pre-states. This review has been compiled based on the guidelines of the American Diabetes Association, the Third Report of the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP III), the European Society of Cardiology, and the European Association for the Study of Diabetes. A systematic approach was developed by the European Society of Cardiology and the European Association for the Study of Diabetes recently to help detect CHD in patients with diabetes and to detect metabolic diseases in patients with CHD.This article is intended for the clinician in everyday practice focusing on the impact of recent advances in the prevention and management of CHD in diabetic patients and the background behind it.

References

1 American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. Diabetes Care. 1998; 21(9): 1551–1559. Review.
10.2337/diacare.21.9.1551
PubMed Google Scholar
2 American Diabetes Association website for the pre-diabetes. http://www.diabetes.org/pre-diabetes.jsp . Accessed January 30, 2008.
Google Scholar
3 Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28(1): 88–136.
CAS PubMed Web of Science® Google Scholar
4 Third report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. US Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute. Circulation. 2002; 106:3143.
Google Scholar
5 De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003; 10:S1.
PubMed Google Scholar
6 Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229.
10.1056/NEJM199807233390404
CAS PubMed Web of Science® Google Scholar
7 Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438): 937–952.
10.1016/S0140-6736(04)17018-9
PubMed Web of Science® Google Scholar
8 The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Diabetes Metab. 2000; 26(4): 282–286.
PubMed Web of Science® Google Scholar
9 Scognamiglio R, Negut C, Ramondo A, et al. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006; 47: 65.
10.1016/j.jacc.2005.10.008
PubMed Web of Science® Google Scholar
10 Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in normotensive men with well-controlled Type II diabetes. Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001; 24: 5–10.
10.2337/diacare.24.1.5
CAS PubMed Google Scholar
11 Annonu AK, Fattah AA, Mokhtar MS, et al. Left ventricular systolic and diastolic functional abnormalities in asymptomatic patients with non-insulin-dependent diabetes mellitus. J Am Soc Echocardiogr. 2001; 14: 885–891.
10.1067/mje.2001.112892
CAS PubMed Web of Science® Google Scholar
12 Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004; 27:1954.
10.2337/diacare.27.8.1954
PubMed Web of Science® Google Scholar
13 American Diabetes Association. Standards of medical care in diabetes—2006. Diabetes Care. 2006; 29(suppl 1): S4.
PubMed Web of Science® Google Scholar
14 Gibbons RJ, Balady GJ, Timothy Bricker J, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002; 40: 1531.
10.1016/S0735-1097(02)02164-2
PubMed Web of Science® Google Scholar
15 Zellweger MJ, Hachamovitch R, Kang X. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004; 25(7): 543–550.
10.1016/j.ehj.2004.02.013
PubMed Web of Science® Google Scholar
16 Rajagopalan N, Miller TD, Hodge DO, et al. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005; 45: 43.
10.1016/j.jacc.2004.06.078
PubMed Web of Science® Google Scholar
17 Sobel BE, Frye R, Detre KM. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2003; 107: 636.
10.1161/01.CIR.0000048897.03553.E4
PubMed Web of Science® Google Scholar
18 Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002; 105(1): 32–40.
10.1161/hc5001.100528
PubMed Web of Science® Google Scholar
19 Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normalstress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003; 41: 1329.
10.1016/S0735-1097(03)00125-6
PubMed Web of Science® Google Scholar
20 Jonas M, Reicher-Reiss H, Boyko V, et al. Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Am J Cardiol. 1996; 77: 1273–1277.
10.1016/S0002-9149(96)00191-9
CAS PubMed Web of Science® Google Scholar
21 Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999; 99(20): 2626–2632.
10.1161/01.CIR.99.20.2626
CAS PubMed Web of Science® Google Scholar
22 Giugliano D, Acampora R, Marfella R, et al. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Ann Intern Med. 1997; 126: 955.
10.7326/0003-4819-126-12-199706150-00004
CAS PubMed Web of Science® Google Scholar
23 The Bypass Angioplasty Revascularization Investigation/(BARI) Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation. 1997; 96: 1761–1769.
10.1161/01.CIR.96.6.1761
PubMed Google Scholar

Citing Literature

Volume4, Issue2

Spring 2009

Pages 107-112

Screening Guidelines for Coronary Heart Disease in Diabetes: Current Recommendations

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Screening Guidelines for Coronary Heart Disease in Diabetes: Current Recommendations

Abstract

References

Citing Literature

References

Related

Information